Tag: Benchmark Investments
Protagenic Therapeutics, Inc. Announces Closing of $13.2 Million Public Offering and...
New York, April 29, 2021 (GLOBE NEWSWIRE) -- Protagenic Therapeutics, Inc. (NASDAQ:PTIX) ("PTIX" or "Company") today announced the closing of an...